6936 — Vetnostrum Animal Health Co Balance Sheet
0.000.00%
- TWD2.49bn
- TWD2.22bn
- TWD1.29bn
- 96
- 53
- 16
- 58
Annual balance sheet for Vetnostrum Animal Health Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 103 | 79.8 | 91.6 | 104 | 106 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 213 | 249 | 236 | 221 | 246 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 597 | 668 | 717 | 678 | 757 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 830 | 804 | 750 | 695 | 671 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,435 | 1,482 | 1,473 | 1,380 | 1,438 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 341 | 359 | 411 | 310 | 289 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 509 | 515 | 423 | 318 | 308 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 927 | 967 | 1,050 | 1,062 | 1,130 |
| Total Liabilities & Shareholders' Equity | 1,435 | 1,482 | 1,473 | 1,380 | 1,438 |
| Total Common Shares Outstanding |